Verus Capital Partners LLC Sells 200 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Verus Capital Partners LLC reduced its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 30.8% in the fourth quarter, HoldingsChannel reports. The firm owned 450 shares of the biotechnology company’s stock after selling 200 shares during the period. Verus Capital Partners LLC’s holdings in Axon Enterprise were worth $267,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Geode Capital Management LLC increased its holdings in Axon Enterprise by 2.0% in the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after purchasing an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP increased its holdings in Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC increased its holdings in Axon Enterprise by 13.9% in the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after purchasing an additional 83,265 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Axon Enterprise by 1.6% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after purchasing an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment bought a new stake in Axon Enterprise in the third quarter worth approximately $200,000. 79.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on AXON shares. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Northland Securities upped their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. The Goldman Sachs Group upped their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, Craig Hallum lowered Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price on the stock. in a research report on Thursday, February 20th. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $587.38.

Axon Enterprise Trading Up 0.6 %

Shares of Axon Enterprise stock opened at $528.45 on Friday. The stock has a fifty day simple moving average of $609.55 and a 200 day simple moving average of $524.28. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The company has a market capitalization of $40.30 billion, a P/E ratio of 136.55, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Insider Buying and Selling

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 2,304 shares of the company’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total value of $1,508,636.16. Following the completion of the transaction, the insider now owns 128,542 shares in the company, valued at $84,168,016.18. This represents a 1.76 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 8,711 shares of company stock worth $5,631,561. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.